Rhabdomyolyse causée par la simvastatine chez un transplanté cardiaque sous ciclosporine
- 29 February 1992
- journal article
- research article
- Published by Elsevier BV in La Revue de Médecine Interne
- Vol. 13 (1), 61-63
- https://doi.org/10.1016/s0248-8663(05)80013-x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemiaArchives of Internal Medicine, 1991
- Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapyJama-Journal Of The American Medical Association, 1990
- The role of cholesterol‐lowering agents in drug‐induced rhabdomyolysis and polymyositisArthritis & Rheumatism, 1989
- Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in vivoBiochemical and Biophysical Research Communications, 1989
- Rhabdomyolysis and renal injury with lovastatin use. Report of two cases in cardiac transplant recipientsPublished by American Medical Association (AMA) ,1988
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- Rhabdomyolysis in Patients Receiving Lovastatin after Cardiac TransplantationNew England Journal of Medicine, 1988
- Myolysis and Acute Renal Failure in a Heart-Transplant Recipient Receiving LovastatinNew England Journal of Medicine, 1988